Oral solid dosage (OSD) forms, such as tablets and capsules, are among the most widely used pharmaceutical products due to their convenience, stability, and precise dosing.
The manufacturing of these forms involves intricate processes, including formulation, granulation, compression, coating, and stringent quality control, collectively known as the solid dose manufacturing process.
Several companies have distinguished themselves in this field, offering advanced capabilities and innovative solutions.
Here are the top five oral solid dosage manufacturing companies.
| Rank | Company Name | Website |
| 1 | Catalent, Inc. | https://www.catalent.com/ |
| 2 | Lonza Group AG | https://www.lonza.com/ |
| 3 | Aenova Group | https://www.aenova-group.com/ |
| 4 | Recipharm AB | https://www.recipharm.com/ |
| 5 | Patheon Pharma Services (Thermo Fisher Scientific) | https://www.patheon.com/ |
Headquarters: Somerset, New Jersey, USA
Year Founded/Established: 2012
Catalent is a leader in drug development and delivery technologies, specializing in OSD forms.
The company offers comprehensive services encompassing the entire solid dose pharmaceutical manufacturing spectrum, from pre-formulation to commercial production.
Catalent’s expertise includes advanced delivery technologies, controlled-release formulations, and bioavailability enhancement, positioning them at the forefront of OSD innovation.
Headquarters: Swiss Alps
Year Founded/Established: 1897
Lonza provides extensive OSD manufacturing services, including granulation, compression, and coating processes.
The company collaborates with biotech firms to develop novel therapies, leveraging its robust infrastructure and technical expertise to support complex solid dose manufacturing processes.
Lonza’s commitment to quality and innovation has made it a trusted partner in the pharmaceutical industry.
Headquarters: Germany
Year Founded/Established: 2008
Aenova is renowned for its high-quality OSD contract manufacturing, producing a wide range of tablets and capsules.
The company has recently expanded its capabilities to include gummy production, responding to the growing demand for alternative dosage forms.
Aenova’s focus on flexibility and customer-centric solutions has solidified its position as a key player among oral solid dosage manufacturing companies.
Headquarters: Stockholm, Sweden
Year Founded/Established: 1995
Recipharm specializes in OSD manufacturing with a focus on high-potency active pharmaceutical ingredients (HPAPIs).
The company utilizes predictive analytics tools to enhance manufacturing efficiency and product quality.
Recipharm’s continuous investment in facility upgrades ensures compliance with evolving industry standards and reinforces its commitment to excellence in solid dose pharmaceutical manufacturing.
Headquarters: Fort Erie, Ontario
Year Founded/Established: 1974
Patheon offers end-to-end OSD manufacturing solutions from formulation development to commercial production.
The company integrates advanced technologies to facilitate efficient scale-up and technology transfer, ensuring seamless progression from the clinical to commercial stages.
Patheon’s global presence and comprehensive services make it a preferred choice for pharmaceutical companies seeking reliable OSD manufacturing partners.
The solid dose pharmaceutical manufacturing landscape is evolving, influenced by several key trends:
The industry is shifting toward continuous manufacturing processes to enhance efficiency, reduce production times, and minimize waste.
This approach allows for more consistent product quality and streamlined operations.
Adherence to current Good Manufacturing Practices (cGMP) and stringent regulatory standards is paramount.
Companies are investing in robust quality management systems to ensure compliance and maintain product integrity.
There is a growing emphasis on implementing eco-friendly practices to minimize environmental impact.
This includes optimizing resource utilization, reducing emissions, and adopting green technologies in the manufacturing process.
While OSD manufacturing offers numerous benefits, it also presents challenges and opportunities:
Managing complex formulations, ensuring supply chain resilience, and navigating stringent regulatory requirements are ongoing challenges.
Additionally, scaling up production while maintaining quality poses significant hurdles.
Technological advancements offer opportunities for developing controlled-release formulations and personalized medicine.
Embracing digitalization and automation can lead to improved efficiency and reduced operational costs.
The future of OSD manufacturing is promising, driven by the rising prevalence of chronic diseases necessitating effective and patient-friendly medication, increasing the demand for OSD forms.
Encouraging partnerships and investments in emerging technologies is crucial to drive efficiency, enhance product quality, and meet evolving patient needs.
Resources:
An overview of oral solid dosage manufacturing
An overview of the top 10 U.S. pharmaceutical companies, highlighting their 2023 revenues and key focus areas.
Explore the top 15 American pharmaceutical companies leading in drug innovation, biotech, and medical advancements.
Explore top pharmaceutical industry software solutions enhancing efficiency, compliance, and innovation in pharma and biotech sectors.
+86-577-67378828
canaan@chinacanaan.com